Vanguard Capital Management’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
OM
KCM
Vanguard Capital Management's GOSS Position: Q3 2026 in Review
Vanguard Capital Management increased its Gossamer Bio (GOSS) stake by 36% in Q3 2026, buying an estimated $557K and bringing the position to 160,648 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3385.
Vanguard Capital Management first reported a position in GOSS in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.09M in Q1 2026. 76 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.
- Vanguard Capital Management held 160,648 shares of Gossamer Bio worth $1.9M as of Q3 2026.
- Vanguard Capital Management bought 42,948 Gossamer Bio shares in Q3 2026, an estimated $557K.
- Gossamer Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3385 holding.
- Vanguard Capital Management first reported a position in Gossamer Bio in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Gossamer Bio position peaked at $3.09M in Q1 2026.
- 76 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.